Page last updated: 2024-11-13

stemofoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

stemofoline: RN given for (2S-(2alpha,3beta,4beta,5alpha,5abeta,6beta,8abeta,9S*))-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID70697717
CHEMBL ID5202018
CHEMBL ID4218051
CHEBI ID69380
MeSH IDM0392749

Synonyms (7)

Synonym
stemofoline
29881-57-0
CHEBI:69380
CHEMBL5202018
CHEMBL4218051
DTXSID901316998
(+)-stemofoline

Research Excerpts

Actions

ExcerptReferenceRelevance
"Stemofoline could increase the accumulation or retention of radiolabeled drugs or fluorescent P-gp substrates in a dose-dependent manner."( Biochemical mechanism of modulation of human P-glycoprotein by stemofoline.
Ambudkar, SV; Chanmahasathien, W; Limtrakul, P; Ohnuma, S, 2011
)
1.33

Toxicity

ExcerptReferenceRelevance
" tuberosa, showing outstanding repellency but no toxic effects."( Feeding deterrence and contact toxicity of Stemona alkaloids-a source of potent natural insecticides.
Brem, B; Greger, H; Hofer, O; Pacher, T; Seger, C; Vajrodaya, S, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1377594Inhibition of P-gp in human KBV1 cells assessed as potentiation of paclitaxel-induced cytotoxicity by measuring fold reduction in paclitaxel IC50 at 5 uM2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1377564Inhibition of P-gp in human KBV1 cells assessed as potentiation of doxorubicin-induced cytotoxicity by measuring fold reduction in doxorubicin IC50 at 5 uM2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1377593Inhibition of P-gp in human KBV1 cells assessed as potentiation of vinblastine-induced cytotoxicity by measuring fold reduction in vinblastine IC50 at 5 uM2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1850569Toxicity in Spodoptera littoralis larvae2022Bioorganic & medicinal chemistry, 08-01, Volume: 67Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (31.82)29.6817
2010's12 (54.55)24.3611
2020's3 (13.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.10 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]